PRVIDEO.TV

Are You FOR or AGAINST California Proposition 29?

California Prop. 29, which is on June 2012 ballot, would increase the cost of a pack of cigarettes in California by $1. Revenue generated from the tax increase, which the state Legislative Analyst's Office projects could reach $735 million annually, would be used to pay for cancer research, smoking cessation programs and tobacco law enforcement. See more information at: http://voterguide.sos.ca.gov/propositions/29/

 Are you for or against prop. 29?

Click here to voice your opinion

SoCalBio Supports Prop. 29 to Mobilize  More Resources for Cancer Research in the State of California

Thursday, May 31 --  4PM - 7PM @ Alfred Mann Foundation for Scientific Research in Santa Clarita:

SoCalBio Networking Forum Focusing on "Mastering the Nuances of Design to Win in an Increasing Competitive MedTech Scape" ........ Click here for more info and to Attend

Friday, June 8 -- 8AM - 5PM @ Saban Research Center in Los Angeles:  

2012 SoCalBio Workshop on "Accessing Government Grant Funding"  ........ Click here for more info and to Attend

SoCalBio Announces Southern California Nominees to the BioGENEius Challenge Award

SoCalBio is pleased  to announce the following Southern California nominees for the BioGENEius Challenge Award:

• Kenneth Lee, a 12th grader at Palos Verdes Peninsula High School (Los Angeles County) whose research project is entitled: "The Role of Testosterone in Hepatocyte Apoptosis in High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease."
•  Jiho Park, a 10th grader at University High School (Orange County) whose research project focuses on: "Modeling Molecular Dynamics Simulations of Membrane-Bound Aromatase Reveal Novel Druggable Sites."

Read Press Release

Congratulations to the  SoCalBio Nominees and We Wish Them the Best of Luck in Boston.

A Recent PhrMA Study Raises Concerns about U.S. Competitivesness in Biopharmaceuticals

Commissioned by Pharmaceutical Research and Manufacturers of America (PhrMA) and conducted by the Battelle Technology partnership, this study examines 18 countries seeking to boost biomed research and development through pro-innovation policies and programs as a major component of their economic growth strategy. The study points out that, "while the U.S. is still a world leader in biopharmaceuticals, as the President and his Jobs Council and others have stated, a range of factors underpin national competitiveness. In an increasingly global economy, the future of U.S. global leadership is not assured" ... Read more

Entitled "Leadership in Decline: Assessing U.S. International Competitiveness in Biomedical Research," the report argues that the United States' leadership position is under threat from intensifying global competition from countries such as China, Germany, Singapore, Sweden and the United Kingdom, all of which have been expanding their financial support for biomedical research and enacting policies to bolster the sector ... Click here to access this report 

Why the Device Tax Will Hurt the U.S. 

Medical Device Industry

Legislation Introduced in the US Senate to Resurrect the Therapeutic Discovery Tax Credit Program

U.S. Sen. Robert Menendez, D-N.J. (phpto right), has introduced legislation to resurrect and expand the Therapeutic Discovery Project that supported medical discovery and job creation by life sciences companies in 2009 and 2010. The program in 2010 provided $1 billion - in the form of grants and tax credits - to nearly 3,000 small companies across the country. Over 25 companies from the Greater Los Angeles region -- many are SoCalBio members -- received such grants in 2010 ... Read more

SoCalBio Applauds the Efforts to Revive and Extend the Therapeutic Discovery Tax Credit Program

Robert Bradway Becomes CEO and Takes the Helm at Biotech Giant Amgen

Biotech drugmaker Amgen Inc. introduced new CEO Robert Bradway (photo right) to shareholders Wednesday at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade running the world's largest biotech company ... Read more

SoCalBio Adds Two Bioscience Women

to its Board of Directors

During its quarterly meeting on Thursday, May 24 at the Los Angeles Chamber of Commerce, members of the SoCalBio Board of Directors unanimously elected Jennifer Neff, PhD, CEO of the Orange County-based Allvivo Vascular and Denise (Dee Dee) DeMan, Chairman & CEO of the Beverly Hills-based Bench International to the Board. 

Jennifer has a PhD degree in Bioengineering from the University of Utah. After serving as a PostDoc Fellow at the Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, she was recruited in 2000 to serve as Medical Director of Allvivo, Inc., the predecessor to Allvivo Vascular. In 2005, she became the Chief Technology Officer of Allvivo after its restructuring as Allvivo Vascular. In 2008, Jennifer took the helm at the company as a CEO .. Read more about Allvivo Vascular

Dee Dee has taken Bench from its founding in 1974 to its eminence today as one of the most successful specialized retained executive search firms in the world. "Dee Dee" is deeply committed to properly "shattering" the glass ceiling for women in the life sciences ... Read more

Click here for full list of SoCalBio Board Members

The San Marino-Based Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans

A physician-initiated Investigational New Drug (P-IND) application submitted to the FDA in late April, 2012, has cleared the FDA's screening process with the requirement for a regular IND application being waived, resulting in the company being able to begin the first of at least two proposed clinical trial sites to investigate a potential oncology treatment developed from Viral Genetics' Metabolic Disruption Technology ... Read more  

ImmunoCellular Therapeutics Receives Approval to Trade on the New York Stock Exchange

"We are pleased to begin trading on NYSE MKT," said Manish Singh, Ph.D. (photo right), President and CEO of ImmunoCellular Therapeutics. "This listing marks an important step in our Company's development by giving us access to a broader investor base and should provide increased transparency and liquidity for investors owning our stock" ... Read more  

• Entry Level Mechanical Engineer

• Project Manager, Antibody Therapeutic Development - Part-Time Consultant

• Inside Sales & Marketing Professional

• Research Assistant -- Coating Formulations

Senior or Principal Quality Engineer 
Mechanical Engineer for Manufacturing Group

Click here to access a list of 11 jobs at Bioness